13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001842545
Total reported value
$603.3M
$603.3M
25 檔
36.6%
The Q3 2024 SEC filing reveals that Eagle Health Investments LP held a total portfolio value of $603.3M, covering 25 public equity positions.
In Q3 2024, Eagle Health Investments LP adopted a defensive or profit-taking posture, trimming 8 positions and completely liquidating 2 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NTRA | Natera Inc | Stock-Healthcare | 10.37% | -3.55% | -9.03% | |
| 2 | ILMN | Illumina Inc | Stock-Healthcare | 9.57% | +1.42% | +21.52% | |
| 3 | ARGX | Argenx Se - Adr | Stock-Healthcare | 7.70% | +2.00% | -15.64% | |
| 4 | ICLR | ICON Public Limited Company | Stock-Healthcare | 7.12% | +1.93% | -12.57% | |
| 5 | INSM | Insmed Inc | Stock-Healthcare | 7.10% | +0.38% | — | |
| 6 | EXK | Exact Sciences CORP | Stock-Materials | 7.02% | — | — | |
| 7 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 5.91% | +1.65% | +7.09% | |
| 8 | DXCM | Dexcom Inc | Stock-Healthcare | 5.73% | — | +63.75% | |
| 9 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 5.61% | — | -41.66% | |
| 10 | BMRN | Biomarin Pharmaceutical Inc | Stock-Healthcare | 5.58% | +0.92% | +80.85% | |
| 11 | INSP | Inspire Medical Systems Inc | Stock-Healthcare | 5.46% | — | — | |
| 12 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 3.97% | — | — | |
| 13 | UTHR | United Therapeutics CORP | Stock-Healthcare | 3.67% | — | -67.70% | |
| 14 | PRCT | Procept Biorobotics CORP | Stock-Other | 3.54% | -2.51% | EXIT | |
| 15 | NBIX | Neurocrine Biosciences Inc | Stock-Healthcare | 2.81% | — | — | |
| 16 | AGIO | Agios Pharmaceuticals Inc | Stock-Other | 2.78% | — | — | |
| 17 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 1.75% | — | — | |
| 18 | FDMT | 4d Molecular Therapeutics In | Stock-Other | 0.95% | — | — | |
| 19 | LNTH | Lantheus Holdings Inc | Stock-Healthcare | 0.90% | — | — | |
| 20 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 0.69% | -0.06% | -73.88% | |
| 21 | VKTX | Viking Therapeutics Inc | Stock-Healthcare | 0.54% | — | — | |
| 22 | TMDX | Transmedics Group Inc | Stock-Healthcare | 0.54% | — | -86.41% | |
| 23 | HOWL | Werewolf Therapeutics Inc | Stock-Other | 0.28% | — | — | |
| 24 | IMCR | Immunocore Holdings Plc-adr | Stock-Other | 0.27% | — | — | |
| 25 | GRAL | Grail Inc | Stock-Healthcare | 0.14% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ILMN | Illumina Inc | +3.7% | +21.52% | Add |
| 2 | EXK | Exact Sciences CORP | +3% | — | Unchanged |
| 3 | NBIX | Neurocrine Biosciences Inc | +2.8% | NEW | New buy |
| 4 | INSP | Inspire Medical Systems Inc | +2.3% | — | Unchanged |
| 5 | BMRN | Biomarin Pharmaceutical Inc | +2.2% | +80.85% | Add |
| 6 | RARE | Ultragenyx Pharmaceutical In | +2.1% | +7.09% | Add |
| 7 | NTRA | Natera Inc | +1.4% | -9.03% | Trim |
| 8 | INSM | Insmed Inc | +1.1% | — | Unchanged |
| 9 | ARGX | Argenx Se - Adr | +1% | -15.64% | Trim |
| 10 | PRCT | Procept Biorobotics CORP | +0.8% | -9.34% | Trim |
| 11 | ALNY | Alnylam Pharmaceuticals Inc | +0.7% | — | Unchanged |
| 12 | LNTH | Lantheus Holdings Inc | +0.3% | — | Unchanged |
| 13 | AGIO | Agios Pharmaceuticals Inc | +0.3% | — | Unchanged |
| 14 | DXCM | Dexcom Inc | +0.3% | +63.75% | Add |
| 15 | VKTX | Viking Therapeutics Inc | +0.1% | — | Unchanged |
| 16 | GRAL | Grail Inc | — | — | Unchanged |
| 17 | IMCR | Immunocore Holdings Plc-adr | 0% | — | Unchanged |
| 18 | HOWL | Werewolf Therapeutics Inc | 0% | — | Unchanged |
| 19 | CRSP | CRISPR Therapeutics AG | -0.1% | — | Unchanged |
| 20 | FDMT | 4d Molecular Therapeutics In | -0.8% | — | Unchanged |
| 21 | ICLR | ICON Public Limited Company | -1.1% | -12.57% | Trim |
| 22 | ISRG | Intuitive Surgical Inc | -1.5% | -73.88% | Trim |
| 23 | UNH | Unitedhealth Group Inc | -2.2% | -41.66% | Trim |
| 24 | TMDX | Transmedics Group Inc | -3% | -86.41% | Trim |
| 25 | GH | Guardant Health Inc | -3.2% | EXIT | Sold out |
| 26 | IQV | Iqvia Holdings Inc | -4.5% | EXIT | Sold out |
| 27 | UTHR | United Therapeutics CORP | -5.7% | -67.70% | Trim |
According to official SEC Form 13F filings, Eagle Health Investments LP reported a total U.S. public equity portfolio value of $603.3M across 25 disclosed positions in Q3 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including NTRA, ILMN, ARGX) accounted for 36.6% of total reported equity market value during Q3 2024.
Top New Position Initiated
NBIX
市值: $14.8M
Top Position Liquidated / Trimmed
IQV
前期市值: $25.8M
During Q3 2024, Eagle Health Investments LP's top holdings by market value included NTRA (10.4%)、ILMN (9.6%)、ARGX (7.7%). The largest single position, NTRA, represented 10.4% of total portfolio value.
In Q3 2024, Eagle Health Investments LP made 15 total portfolio adjustments, initiating 1 new buys, adding to 4 positions, trimming 8 holdings, and fully liquidating 2 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.